These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 17404479

  • 1. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
    Nanki T.
    Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
    [Abstract] [Full Text] [Related]

  • 2. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM, Nishioka K, Yudoh K.
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [Abstract] [Full Text] [Related]

  • 3. Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production.
    Tsuboi H, Udagawa N, Hashimoto J, Yoshikawa H, Takahashi N, Ochi T.
    Arthritis Rheum; 2005 Dec; 52(12):3819-28. PubMed ID: 16320327
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA.
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].
    Hikita A, Tanaka S.
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():84-6. PubMed ID: 15799323
    [No Abstract] [Full Text] [Related]

  • 9. [RANKL as a target molecule for treatment of joint destruction].
    Tanaka S.
    Clin Calcium; 2007 Apr; 17(4):586-92. PubMed ID: 17404489
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T, Hoshino M, Aoki K, Ohya K, Komano Y, Nanki T, Miyasaka N, Umezawa K.
    Arthritis Res Ther; 2007 Apr; 9(5):R97. PubMed ID: 17892600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Molecular determinants in osteoclast differentiation and osteoimmunology].
    Takayanagi H.
    Rinsho Ketsueki; 2009 Jun; 50(6):447-52. PubMed ID: 19571503
    [No Abstract] [Full Text] [Related]

  • 17. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.
    Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, Min SY, Cho YG, Park SH, Kim HY.
    Immunol Lett; 2007 May 15; 110(1):54-64. PubMed ID: 17467812
    [Abstract] [Full Text] [Related]

  • 18. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes.
    Page G, Miossec P.
    Arthritis Rheum; 2005 Aug 15; 52(8):2307-12. PubMed ID: 16052586
    [Abstract] [Full Text] [Related]

  • 19. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K, Yamamura M, Iwahashi M, Otsuka F, Yamana J, Sunahori K, Kawashima M, Yamada M, Makino H.
    Arthritis Res Ther; 2006 Aug 15; 8(4):R126. PubMed ID: 16859503
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.